Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study

The COVID-19 pandemic is showing an exponential growth, mandating an urgent need to develop an effective treatment. Indeed, to date, a well-established therapy is still lacking. We aimed to evaluate the safety and efficacy of hydroxychloroquine (HCQ) added to standard care in patients with COVID-19....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of tropical medicine and hygiene 2020-10, Vol.103 (4), p.1635-1639
Hauptverfasser:	Abd-Elsalam, Sherief, Esmail, Eslam Saber, Khalaf, Mai, Abdo, Ehab Fawzy, Medhat, Mohammed A, Abd El Ghafar, Mohamed Samir, Ahmed, Ossama Ashraf, Soliman, Shaimaa, Serangawy, Ghada N, Alboraie, Mohamed
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetaminophen - therapeutic use Adult Antiviral Agents - therapeutic use Betacoronavirus - pathogenicity Cephalosporins - therapeutic use Coronavirus Infections - diagnosis Coronavirus Infections - drug therapy Coronavirus Infections - mortality Coronavirus Infections - virology Coronaviruses COVID-19 Drug Administration Schedule Drug Repositioning Egypt Female Humans Hydrocortisone - therapeutic use Hydroxychloroquine - therapeutic use Male Middle Aged Mortality Oseltamivir - therapeutic use Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - drug therapy Pneumonia, Viral - mortality Pneumonia, Viral - virology Respiration, Artificial SARS-CoV-2 Severity of Illness Index Survival Analysis Time Factors Treatment Outcome Ventilation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!